EP 1280529 A2 20030205 - OPIOID ANTAGONIST CONTAINING COMPOSITION FOR ENHANCING THE POTENCY OR REDUCING ADVERSE SIDE EFFECTS OF OPIOID AGONISTS
Title (en)
OPIOID ANTAGONIST CONTAINING COMPOSITION FOR ENHANCING THE POTENCY OR REDUCING ADVERSE SIDE EFFECTS OF OPIOID AGONISTS
Title (de)
ANWENDUNG VON OPIOID ANTAGONISTEN ZUR FÖRDERUNG DER AKTION ODER ZUR VERRINGERUNG VON UNERWÜNSCHTEN NEBENWIRKUNGEN VON OPIOID AGONISTEN
Title (fr)
NOUVELLES COMPOSITIONS ET METHODES DESTINEES A AMELIORER LA PUISSANCE OU REDUIRE LES EFFETS SECONDAIRES INDESIRABLES D'AGONISTES OPIOIDES
Publication
Application
Priority
- US 0114644 W 20010504
- US 20226800 P 20000505
- US 20222700 P 20000505
- US 56607100 A 20000505
- US 0012493 W 20000505
- US 24448200 P 20001030
- US 24511000 P 20001101
- US 24623500 P 20001102
- US 75633101 A 20010108
Abstract (en)
[origin: WO0185150A2] The invention generally relates to novel compositions and methods with an opioid agonist and an opioid antagonist to differentially dose a human subject so as to either enhance analgesic potency without attenuating an adverse side effect of the agonist, or alternatively maintain the analgesic potency of the agonist while attenuating an adverse side effect of the agonist. The invention additionally relates to novel opioid compositions and methods for the gender-based dosing of men and women.
[origin: WO0185150A2] 0he invention generally relates to novel compositions and methods with an opioid agonist and an opioid antagonist to differentially dose a human subject so as to either enhance analgesic potency without attenuating an adverse side effect of the agonist, or alternatively maintain the analgesic potency of the agonist while attenuating an adverse side effect of the agonist. The invention additionally relates to novel opioid compositions and methods for the gender-based dosing of men and women.
IPC 1-7
IPC 8 full level
A61K 9/20 (2006.01); A61K 9/48 (2006.01); A61K 9/50 (2006.01); A61K 31/00 (2006.01); A61K 31/135 (2006.01); A61K 31/167 (2006.01); A61K 31/445 (2006.01); A61K 31/485 (2006.01); A61K 45/06 (2006.01); A61P 25/04 (2006.01); A61P 29/00 (2006.01); A61P 43/00 (2006.01)
CPC (source: EP)
A61K 9/2018 (2013.01); A61K 9/2054 (2013.01); A61K 9/4858 (2013.01); A61K 9/4866 (2013.01); A61K 9/5042 (2013.01); A61K 9/5084 (2013.01); A61K 31/00 (2013.01); A61K 31/135 (2013.01); A61K 31/445 (2013.01); A61K 31/485 (2013.01); A61K 45/06 (2013.01); A61P 25/04 (2017.12); A61P 29/00 (2017.12); A61P 43/00 (2017.12)
Citation (search report)
See references of WO 0185150A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0185150 A2 20011115; WO 0185150 A3 20020808; AU 2001259458 B2 20060914; AU 2001259560 B2 20070215; AU 5956001 A 20011120; CA 2408098 A1 20011115; EP 1280529 A2 20030205; JP 2004501094 A 20040115
DOCDB simple family (application)
US 0114644 W 20010504; AU 2001259458 A 20010504; AU 2001259560 A 20010504; AU 5956001 A 20010504; CA 2408098 A 20010504; EP 01933110 A 20010504; JP 2001581804 A 20010504